Champions Oncology Statistics Share Statistics Champions Oncology has 13.79M
shares outstanding. The number of shares has increased by 1.71%
in one year.
Shares Outstanding 13.79M Shares Change (YoY) 1.71% Shares Change (QoQ) 0% Owned by Institutions (%) 43.19% Shares Floating 5.2M Failed to Deliver (FTD) Shares 2,567 FTD / Avg. Volume 7.33%
Short Selling Information The latest short interest is 92.02K, so 0.67% of the outstanding
shares have been sold short.
Short Interest 92.02K Short % of Shares Out 0.67% Short % of Float 1.37% Short Ratio (days to cover) 2.37
Valuation Ratios The PE ratio is 20.78 and the forward
PE ratio is 42.6.
Champions Oncology's PEG ratio is
-0.13.
PE Ratio 20.78 Forward PE 42.6 PS Ratio 1.72 Forward PS 1.4 PB Ratio 25.89 P/FCF Ratio 13.96 PEG Ratio -0.13
Financial Ratio History Enterprise Valuation Champions Oncology has an Enterprise Value (EV) of 93.99M.
EV / Sales 1.65 EV / EBITDA 14.49 EV / EBIT 12.73 EV / FCF 13.43
Financial Position The company has a current ratio of 0.94,
with a Debt / Equity ratio of 1.62.
Current Ratio 0.94 Quick Ratio 0.94 Debt / Equity 1.62 Debt / EBITDA 0.94 Debt / FCF 0.87 Interest Coverage 168.63
Financial Efficiency Return on Equity is 124.63% and Return on Invested Capital is 46.44%.
Return on Equity 124.63% Return on Assets 14.53% Return on Invested Capital 46.44% Revenue Per Employee $271.16K Profits Per Employee $22.39K Employee Count 210 Asset Turnover 1.76 Inventory Turnover n/a
Taxes Income Tax -75K Effective Tax Rate -1.62%
Stock Price Statistics The stock price has increased by 33.47% in the
last 52 weeks. The beta is 0.51, so Champions Oncology's
price volatility has been higher than the market average.
Beta 0.51 52-Week Price Change 33.47% 50-Day Moving Average 6.8 200-Day Moving Average 7.98 Relative Strength Index (RSI) 44.02 Average Volume (20 Days) 35,017
Income Statement In the last 12 months, Champions Oncology had revenue of 56.94M
and earned 4.7M
in profits. Earnings per share was 0.34.
Revenue 56.94M Gross Profit 28.55M Operating Income 4.55M Net Income 4.7M EBITDA 6.49M EBIT 4.85M Earnings Per Share (EPS) 0.34
Full Income Statement Balance Sheet The company has 9.79M in cash and 6.11M in
debt, giving a net cash position of 3.68M.
Cash & Cash Equivalents 9.79M Total Debt 6.11M Net Cash 3.68M Retained Earnings -79.89M Total Assets 30.55M Working Capital -1.68M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 7.39M
and capital expenditures -389K, giving a free cash flow of 7M.
Operating Cash Flow 7.39M Capital Expenditures -389K Free Cash Flow 7M FCF Per Share 0.51
Full Cash Flow Statement Margins Gross margin is 50.15%, with operating and profit margins of 8% and 8.26%.
Gross Margin 50.15% Operating Margin 8% Pretax Margin 8.12% Profit Margin 8.26% EBITDA Margin 11.39% EBIT Margin 8% FCF Margin 12.29%
Dividends & Yields CSBR does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 4.81% FCF Yield 7.16%
Dividend Details Analyst Forecast The average price target for CSBR is $12,
which is 90.5% higher than the current price. The consensus rating is "Strong Buy".
Price Target $12 Price Target Difference 90.5% Analyst Consensus Strong Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $8.5 Lynch Upside 34.92% Graham Number 1.46 Graham Upside -76.83%
Stock Splits The last stock split was on Aug 12, 2015. It was a
backward
split with a ratio of 1:12.
Last Split Date Aug 12, 2015 Split Type backward Split Ratio 1:12
Scores Altman Z-Score -0.03 Piotroski F-Score 5
